MAPT and Alzheimer disease: Progressive accumulation and spread of tau pathology in the AD brain are intimately associated with neurodegeneration and cognitive symptoms (Bejanin et al., 2017; Giannakopoulos et al., 2003), highlighting tau propagation as a potential therapeutic target.